Asosiy kontentga oʻtish
Maqola

Diagnostic and treatment options for patients with COPD as part of real clinical practice. Approaches to the treatment of patients with various phenotypes according to GOLD (2019): materials of the Council of Experts of the Siberian Federal District, Chita and Buryatia, dated 03.15.19

И. В. ДемкоV.F.Voyno-Yasenetskiy Krasnoyarsk State Medical University, Healthcare Ministry of Russia; Krasnoyarsk State Territorial Clinical HospitalL. M. KudelyaElena A. SobkoV.F.Voyno-Yasenetskiy Krasnoyarsk State Medical University, Healthcare Ministry of Russia; Krasnoyarsk State Territorial Clinical HospitalIrina A. SolovevaV.F.Voyno-Yasenetskiy Krasnoyarsk State Medical University, Healthcare Ministry of Russia; Krasnoyarsk State Territorial Clinical HospitalТрофименко Ирина НиколаевнаIrkutsk State Medical Academy of Postgraduate Education – Branch Campus of the Federal State Budgetary Educational Institution of Further Professional Education "Russian Medical Academy of Continuing Professional Education" of the Ministry of Healthcare of the Russian FederationТетенева Анна ВалентиновнаSiberian State Medical University, Healthcare Ministry of RussiaAnastasia GrebenyukBarnaul Regional City Hospital No.5N. G. GanyukovaН. С. ГыргешкиноваS. А. LukyanovChita State Medical Academy, Healthcare Ministry of RussiaCh. Ch. MandarzhapRepublican Specialized Scientific and Practical Medical Center of Oncology and RadiologyO. A. Meshcheryakova
2020en
ABI

Annotatsiya

Chronic obstructive pulmonary disease (COPD) is a global problem in modern medicine. In recent years, the medical community’s understanding of COPD has changed significantly, which is primarily due to the emergence of a new classification and the identification of various phenotypes of the disease. These changes could not affect the tactics of COPD treatment. The article discusses not only the debatable issues of treating COPD; it provides an overview of changes in international (Global Initiative for Chronic Obstructive Lung Disease, 2018) and national (2019) recommendations, but also the significance and benefits of triple therapy in terms of evidence-based medicine as well as the benefits of extra-fine drugs in the treatment of bronchial obstructive syndrome.

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar